Advanced Probiotic Suggestions

In a clinical setting, a practitioner may conceptually believe that a patient would benefit from a probiotic. The problem is which one(s). Often the advice is a generic “take a good probiotic”; a suggestion bordering on magical thinking.
Video version below.

Level 1: Using Published Studies

In general, published studies use specific strains of probiotics. Those strains may not be readily available. Often, the suggestion would be to take the same species (with fingers crossed).

For those that wish to avoid this wishful thinking, we have a page listing Research Probiotics available Retail. This allows you to do a quick search. For example, for ADHD we have just two strains listed as shown below. For some conditions, nothing will be found. These are links to studies or reviews that need to be reviewed by the practitioner.

The basic issue is a lack of studies. Comparison studies are usually non-existant.

Level 2: Identifying cause of condition(s) and targeting taxa

Often this is done by using microbiome analysis looking for abnormal levels of bacteria and seeing what will alter them. For example, multiple studies report low levels of Faecalibacterium and high levels of Bifidobacterium for ADHD. As above, we have a search page that links to studies of the impact of different probiotics (and supplements) on each bacteria.

Level 3: Identifying cause using Enzymes and Metabolites

At this point we enter into the Citizen Science world at Microbiome Prescription. Thousands of people have uploaded their microbiome samples from a host of different providers and then annotated the samples with their symptoms and conditions. The data is at MicrobiomePrescription Citizen Science.

The chart below shows the process. The number of abnormal bacteria (too high or too low) is much larger than published studies — not unexpected given the much larger sample size.

Abstraction

We take the microbiome data and transformed it with data from KEGG: Kyoto Encyclopedia of Genes and Genomes to get estimates of enzymes and metabolites or compounds. This data is processed thru a variety of methods to determine associations of the enzymes and metabolites to condition.

What we observe is that at the metabolite level we often have agreement across the three most common providers

At the enzyme level, we do not get this strong pattern

Nor do we get it by the bacteria associated.

Apparent Conclusion

The cause of the symptom or diagnosis appears to be an imbalance of the metabolites. Metabolites levels are the results of multiple bacteria and not a specific bacteria.

Monte Carlo Selection of Probiotics

As a proof of concept, I applied algorithms to the above with the following being the top items suggested (in descending priority). Play with it on Symptom Association Studies.

  • Taxa Based — Select probiotics based on abnormal bacteria shifts
  • Enzyme Based — Select probiotics based on enzymes that are deficient in the condition, but know to be produced by the probiotic
  • Metabolite Based — Select probiotics based on metabolites that are deficient in the condition, which the probiotic impacts
Taxa BasedEnzyme BasedMetabolite Based
clostridium butyricum ,Miya,Miyarisan
Lentilactobacillus kefiri {Kefibios}
bifidobacterium lactis,streptococcus thermophilus probiotic
pediococcus acidilactic {RBB9 PEDIOCOCCUS ACIDILACTI}
Bifidobacterium animalis
Lacticaseibacillus paracasei shirota {Yakult}
bifidobacterium infantis {B. infantis}
lactobacillus helveticus {L. helveticus}
Bifidobacterium animalis subsp. lactis {B. Lactis}
lactobacillus reuteri
bifidobacterium longum,lactobacillus helveticus
Levilactobacillus brevis {L.brevis}
Bacillus pumilus {B. pumilus}
lactobacillus salivarius
Lactobacillus Johnsonii {Lactobacillus Johnsonii}
lactobacillus paracasei,lactobacillus acidophilus,bifidobacterium animalis
lactobacillus paracasei
Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus {Bio-three}
Lentilactobacillus buchneri {Lactobacillus buchneri}
Lactobacillus kefiranofaciens {Kefir Probiotic}
bifidobacterium pseudocatenulatum li09,bifidobacterium catenulatum li10
mutaflor escherichia coli nissle 1917
enterococcus faecium (probiotic)
Pediococcus pentosaceus
lactobacillus helveticus,lactobacillus rhamnosus
Bifidobacterium longum subsp. longum BB536 {BB536}
lactobacillus plantarum,xylooligosaccharides,
lactobacillus crispatus {L. Crispatus}
Enterococcus faecium sf 68 {bioflorin}
aspergillus oryzae {koji}
lactobacillus casei
Bifidobacterium breve {B. breve}
Latilactobacillus sakei {Lactobacillus sakei}
Arthrospira platensis {Spirulina}
Brevibacillus laterosporus {B. laterosporus }
Lactobacillus jensenii {L Jensenii}
Escherichia coli cryodesiccata {colinfant probiotics}
Finnish Probiotic {Valio Probiotic}
Alkalihalobacillus clausii {Bacillus clausii }
bifidobacterium bifidum
bacillus subtilis,lactobacillus acidophilus
Limosilactobacillus fermentum (probiotic)
Bifidobacterium catenulatum subsp. catenulatum {Bifidobacterium catenulatum}
Escherichia coli:DSM 16441-16448 {symbioflor-2}
lactobacillus plantarum
bacillus subtilis natto {B.natto}
Lactiplantibacillus pentosus {L. pentosus}
Bacillus amyloliquefaciens group {B. Amyloliquefaciens}
Lactococcus lactis {Streptococcus lactis}
Lactobacillus gasseri {L.gasseri}
Pseudomonas fluorescens
Pseudomonas putida
Escherichia coli
Azospirillum lipoferum
Azospirillum brasilense
Cereibacter sphaeroides
Rhodospirillum rubrum
Streptomyces venezuelae
Azotobacter vinelandii
Rhodococcus rhodochrous
Azotobacter chroococcum
Pimelobacter simplex
Acinetobacter calcoaceticus
Priestia megaterium
Streptomyces fradiae
Brevibacillus brevis
Bacillus thuringiensis
Peribacillus simplex
Paenibacillus polymyxa
Bacillus subtilis
Arthrobacter citreus
Brevibacillus laterosporus
Arthrobacter agilis
Bacillus amyloliquefaciens
Alkalihalophilus pseudofirmus
Bacillus velezensis
Bacillus subtilis subsp. natto
Heyndrickxia oleronia
Bacillus pumilus
Shouchella clausii
Cellulosimicrobium cellulans
Bacillus licheniformis
Cellulomonas fimi
Lentibacillus amyloliquefaciens
Clostridium beijerinckii
Corynebacterium stationis
Heyndrickxia coagulans
Micrococcus luteus
Clostridium butyricum
Lactiplantibacillus plantarum
Bifidobacterium longum subsp. infantis
Bifidobacterium breve
Bifidobacterium pseudocatenulatum
Enterococcus faecalis
Bifidobacterium longum subsp. longum
Enterococcus faecium
Lacticaseibacillus paracasei
Lactococcus cremoris
Bifidobacterium longum
Lactiplantibacillus pentosus
Bifidobacterium breve
Bifidobacterium pseudocatenulatum
Bifidobacterium longum subsp. infantis
Bifidobacterium bifidum
Bifidobacterium longum
Bifidobacterium catenulatum
Bifidobacterium adolescentis
Bifidobacterium longum subsp. longum
Bifidobacterium animalis subsp. lactis
Pediococcus pentosaceus
Pediococcus acidilactici
Lactobacillus acidophilus
Brevibacillus brevis
Escherichia coli
Lactobacillus delbrueckii subsp. bulgaricus
Limosilactobacillus reuteri
Lactobacillus gasseri
Lactobacillus jensenii
Lactobacillus johnsonii
Enterococcus durans
Lactobacillus helveticus
Pseudomonas putida
Streptococcus thermophilus
Limosilactobacillus fermentum
Ligilactobacillus salivarius
Levilactobacillus brevis
Lactobacillus kefiranofaciens
Lactobacillus crispatus
Lentilactobacillus kefiri
Leuconostoc mesenteroides
Arthrobacter agilis
Micrococcus luteus
Lactococcus cremoris
Leuconostoc lactis
Alkalihalophilus pseudofirmus
Lactococcus lactis
Priestia megaterium
Corynebacterium stationis
Acinetobacter calcoaceticus
Anaerobutyricum hallii
Brevibacillus laterosporus
Lactiplantibacillus plantarum
Streptomyces fradiae
Pimelobacter simplex
Cellulomonas fimi
Lactiplantibacillus pentosus
Bacillus licheniformis
Lacticaseibacillus casei
Lacticaseibacillus rhamnosus
Lentibacillus amyloliquefaciens

Some probiotics are high on all three lists, for example: E.Coli. Others are not. I am inclined to using enzymes as the preferred abstraction. Metabolites have a very nice clustering, but at present deriving probiotics is not as clean and simple as desired. A more complex model is needed.

What have we learnt:

  • There may not be studies on probiotics for a specific condition
  • There are studies on probiotics that shifts some taxa. Things can become complex when there are multiple taxa in scope (as well as reliability of taxa identification)
  • From the KEGG Enzymes estimated from a sample, we can derive the enzyme producing probiotics that may conceptually help
    • Note: Organic Acid Test (OATS) report on many of these enzymes and can be used to validate estimates. Additionally, OATS tests can be used to select probiotics for the reported deficiencies
  • From the KEGG metabolites estimated from a sample, we can supplement with the deficiency where practical, or look for probiotics that produces deficient metabolites.

The Enzymes and Metabolite approaches should produce reasonable candidates for future clinical studies.

Patient Specific Suggestions

The above exploration analysis was done ignoring the amount of bacteria in a specific example (and thus enzymes and metabolites). It also ignored whether there is duplication of enzymes and metabolites in the probiotics. Ideally, you want a full coverage of enzymes and metabolites.

https://youtu.be/Z9qXyEVQlus

Medical Beliefs vs Actuary Tables

I have known for years that conventional MD knowledge often trail science by generations. It means that patients need to educate themselves (and in some cases, their MD). The first example is simple:

Stress being the Cause of Ulcers

The discovery that ulcers are caused by bacteria, specifically Helicobacter pylori, was made by Australian researchers Barry Marshall and Robin Warren in 1982. They identified H. pylori as a major cause of gastritis and peptic ulcer disease, challenging the prevailing belief that stress and lifestyle factors were the primary causes of ulcers.[23 years of the discovery of Helicobacter pylori: Is the debate over?]. In 1994, the National Institutes of Health (NIH) held a consensus meeting that concluded the key to treating gastric and duodenal ulcers was the detection and eradication of H. pylori. Then it spent the next decade educating MDs.

But wait! John Lykoudis, MD. after treating himself for peptic ulcer disease with antibiotics in 1958 and finding the treatment effective, Lykoudis began treating patients with antibiotics. After experimenting with several combinations of antibiotics he eventually arrived at a combination which he termed Elgaco and which he patented in 1961. So it took 4 decades from demonstration to acceptable practice.

BMI and Life Expectancy

If you go to CDC Calculator for BMI, Age is not a factor

“One BMI will rule them all”. Except, if we are talking about health — this is wrong

Older adults with BMI <25 and >35 kg/m2 were at a higher risk of a decrease in functional capacity, and experienced gait and balance problems, fall risk, decrease in muscle strength, and malnutrition. Data from this study suggest that the optimum range of BMI levels for older adults is 31–32 and 27–28 kg/m2 for female and male, respectively.

Going to What is the Optimal Body Mass Index Range for Older Adults? [2022]

Where as CDC shows this evaluation and would encourage older people to move to an unhealthy BMI. As a FYI, I am at 31.7 and working to reduce to 28 using probiotics see Probiotics, Obesity and Diabetes.

Blood Pressure and Stroke Risks

For those over 65, a recent study Association of Blood Pressure With Stroke Risk, Stratified by Age and Stroke Type, in a Low-Income Population in China: A 27-Year Prospective Cohort Study [2019] found some very interesting results. If you over 65 and have BP < 130, you actually have an increased risk of stroke (i.e. 1/.80) = 25% greater odds of having a stroke then if you were in the 130-140 range. In the 140-150 range, it is a toss up — with odds of one type of stoke still low and the other marginally increasing.

Among older Japanese adults with isolated systolic hypertension and baseline SBP values ≥160 mm Hg, the on-treatment SBP level at which CVD event risks and all-cause mortality were minimized was 130 to < 145 mmHg. On-treatment SBP values of < 130 or ≥145 mmHg were associated with increased CVD event risk and all-cause mortality.

On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension [2017]

Isolated systolic hypertension (ISH) is a condition characterized by an elevated systolic blood pressure (the top number) of 130 mm Hg or higher, while the diastolic blood pressure (the bottom number) remains below 80 mm Hg

Bottom Line

The reality is that your MD knowledge may be stale and not in agreement with the latest research. Use the US National Library of Medicine to find the latest research — be specific for age and gender in your research. Share it with your MD.

Long COVID and Hypoxia (brain fog)

Long COVID [Post COVID Syndrome] is likely an immature variant of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). I use the term immature because typically a ME/CFS diagnosis comes 2-10 years after on-set. Between onset and a later static state, the microbiome is a state of constant transition attempting to reach a new stable state.

Doing a search on Pub Med for “Long COVID hypoxia”, we get over 200 hits. Searching for “Long COVID coagulation”, we get over 300 hits! The following are quick notes to sketch out avenues for people treating Long COVID, especially patients with brain fog. I have cited classic ME/CFS literature and matching literature on Long COVID. This is a page in progress and may be updated periodically.

How can Hypoxia happen?

There are many ways, here’s a recap:

  • Coagulation Issues: Often it is an inherited coagulation defect that flares as a side-effect of post COVID changes (likely of the microbiome). See Thick Blood, Clots dimension of CFS.
    • Coagulation is a complex process and “taking a baby aspirin” is NOT a cure all.
    • The defect may be in just one or several of the Roman Numeral items shown below. (From Coagulation Cascade)
    • The result is often called “Thick Blood”
    • See this Johns Hopkins “What Does COVID Do to Your Blood?

Some Signs of the Above

  • Objectively measured abnormalities of blood pressure variability in CFS[2012]
  • Lower blood pressure in sleep[2011]
  • Lower blood pressure[2009]
  • Rapid Heart Beat (Tachycardia) (more info) – because of lower delivery per heart beat, the heart beats more trying to deliver more oxygen
  • Small heart on X-Rays
  • Low Iron Levels (definition of low should likely be below average, not the lab ranges)
  • Saturated O2 level being slightly low

Treatment Options

Hemoglobin improvement

Coagulation

Microbiome

Keeping Supplement Costs Under Control

A few years ago I wrote A Frugal List of Supplements for ME/CFS using knowledge at that time trying to rank order supplements that may help by best cost. Today a similar question came up. I am retired (72 y.o.) and working part time with a variety of complex conditions in the household so getting the right stuff at reasonable cost is a priority.

In this post I will share what our current strategies are and illustrate cost savings. For making our own capsules, I have ignored the cost (since it is low).

Example #1 Supplement Hesperidin

Choice #1: Off the shelf: 13.57 / ( 0.500 g x 60) = $0.45 per gram

Choice #2: Bulk Powder off Amazon. $16.96/ 100 grams = $0.17 /gram

Choice #3: Buying direct from a manufacturer in bulk (but certified organic): 24.14 /100 = $.24 / gram (with free shipping)

Example #2 Lactobacillus Plantarum

Choice #1: Off the shelf: 30 capsules with 10 BCFU: $12.42 / (30 x 10) = $0.04 / BCFU

Choice #2: Bulk Probiotics as powder: 169.17 / (400 x 100) = $0.004 per BCFU. Lower package sizes available at slightly higher cost per BCFU.

Choice #3: Buying direct from a manufacturer in bulk (Organic and typically manufactured within 2 weeks of shipping): $138.73 / (20 x 1000) = $0.007/BCFU. Lowest package is $0.02/BCFU

A key issue is probiotics is time since manufacture, abuse in storage (i.e. not kept is fridges in transit and storage — if you look “behind the scenes” at many health food stores, you will see boxes of probiotics just kept in the back, not refrigerated. They are then put it into the display refrigerator as needed). See Probiotics — what is advertised may not be what you get

Example #3 Herb Turmeric

Choice #1: Off the shelf: $12.49/(1 gm x 60) = $0.21 / gram

Choice #2: Bulk – from Amazon (note this is Organic, above is not): $14.99 / 907g = $0.016 / gram

Choice #3: Oversea supplier (also organic): $18.11 / 100gram = $0.18/gram

Bottom Line: Up to 90% reduction in Supplement Costs is possible

There are always other factors — for example, some probiotics may only be available from just one supplier (i.e. L. Jensenii, E. Coli Nissle 1917). Do you want it to be Organic? Degree of trust in manufacturer, supply chain handling, seller’s handling (I deemed it very unlikely that Probiotics sold by Amazon are refrigerated, more likely just sits in their warehouses until sold).

Also, be pragmatic on likely duration of use. Don’t over buy to “save money” and have it sitting on the shelf forever…

Remember: Most supplements are high profit margins. At least one supplement seller who also sells microbiome testing kits is suspected to sell their kits at below cost because of the profit from selling the supplements to the same customers.

Our own experience with Maple Life Sciences probiotics have been awesome. We see changes in stools within 48 hours when we rotate between probiotics.

Probiotics, Obesity and Diabetes

A study demonstrated Fecal Microbiota Transplantation (FMT) alone can change a skinny mouse into a fat one is detailed in the research published by the journal Science. In this study, researchers transplanted gut bacteria from human twins discordant for obesity into germ-free mice. The mice that received gut bacteria from obese twins grew fat, while those that received bacteria from lean twins remained lean. This experiment provided compelling evidence that gut microbiota can influence body weight and adiposity independently of diet or other factors. Visual below of mice feed identical diet.

My own experience is loosing 30 pounds from the addition of a specific probiotic (Akkermansia) over a year without a change of diet. IMHO, a change of diet along may not do it. Often it takes two things: changing the diet AND changing the bacteria in the gut.

Literature

Probiotics that have the best actual evidence

Note that some probiotics can result in weight gain, so taking random ones is not the way to do it. Many of the studies found effective using probiotics mixtures included Lactobacillus plantarum

Diabetes

While many studies show promise, the evidence is still mixed, and more long-term research is needed to determine the most effective probiotic strains and protocols for diabetes management [Probiotics Contribute to Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis] – study was pre-Akkermansia availability.

And

Bottom Line

My (incomplete) review of the many many studies suggests that four species of probiotics are the most likely to help with Obesity and Diabetes. Below are links to manufacturers that directly sell my preferred single strain probiotics. This means that you will get the probiotics within weeks (or days) of being manufactured (i.e. Very fresh and live probiotics).

Suggested daily dosage is a therapeutic 50 BCFU/day for the Lactobacillus, and likely a capsule of Akkermansia muciniphila (Pendulum is the established provider).

For the Lactobacillus, I find using powder dissolved in a glass of warm water works very well. It often has a side effect of inhibiting wanting to have a treat and gives a satisfied feeling in the gut. Taking them as capsules do not seem to have that effect.

Microbiome Prescription is already in conformity to the new EU AI laws!

We are likely the sole firm claiming the use of AI for microbiome analysis that is in conformity today. Most firms in this area that claim using AI, refuse to even disclose which type of AI that they are using. Since our founding, we have been OPEN DATA. The logic used for every suggestion is show and links to every data source. We are about to file patents for our proprietary, PATENT PENDING, algorithms – meaning that shortly even the algorithms will be available for inspection.

Our core AI model is an old classic: fuzzy logic expert systems.

The foundations of fuzzy logic were laid in 1965 by Lotfi Zadeh, a professor at the University of California, Berkeley. In his seminal paper “Fuzzy Sets”, Zadeh introduced the concept of fuzzy set theory, which allows for degrees of truth rather than the classical binary true or false [A brief History of Fuzzy Logic].

The concept of expert systems, which are computer programs designed to emulate the decision-making abilities of a human expert, began to take shape in the 1960s. One of the earliest and most notable examples was MYCIN, developed in the early 1970s at Stanford University. MYCIN was designed to diagnose bacterial infections and recommend antibiotics based on a set of if-then rules derived from expert knowledge. [Knowledge Discovery from Medical Data and Development of an Expert System in Immunology]